Wikidata

(Q65543075)

English

JUPITER - Crestor 20mg Versus Placebo in Prevention of Cardiovascular (CV) Events

clinical trial

  • JUPITER trial
In more languages

Statements

title
A Randomized, Double-Blind, Placebo Controlled, Multicenter, Phase 3 Study of Rosuvastatin (CRESTOR®) 20 mg in the Prevention of Cardiovascular Events Among Subjects With Low Levels of Low Density Lipoprotein(LDL) Cholesterol & Elevated Levels of C-Reactive Protein (English)
0 references
country
Argentina
0 references
Belgium
0 references
Brazil
0 references
Bulgaria
0 references
Canada
0 references
Chile
0 references
Colombia
0 references
Costa Rica
0 references
Denmark
0 references
El Salvador
0 references
Estonia
0 references
Germany
0 references
Israel
0 references
Mexico
0 references
Netherlands
0 references
Norway
0 references
Panama
0 references
Poland
0 references
Romania
0 references
South Africa
0 references
Switzerland
0 references
United Kingdom
0 references
Uruguay
0 references
Venezuela
0 references
start time
February 2003
0 references
end time
September 2008
0 references
number of participants
17,802
0 references
minimum age
50 year
0 references

Identifiers

Freebase ID
/m/05c46yk
0 references
 
edit
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  Retrieved from "https://www.wikidata.org/w/index.php?title=Q65543075&oldid=1858522047"